Early Stage Drug Development Company
We develops synthetic drugs and natural products-derived ND applying new
technology and API (active pharmaceutical ingredient) produces
About ArcaEir
Company Overview
Division | Content |
---|---|
Company Name | ArcaEir Inc. |
CEO | Byong-Cheol Shin |
Establishment date | June 28, 2013 |
Capital | KRW 1,110,242,000 |
Issued stock | No. of Common stock : 2,220,484 |
Main skills |
|
Executives & Staff members | 9 persons |
IPO Plan | Planning KOSDAQ market listing |
Patent | Registration no. 11(including US registration no. 1) |